Gary R. Mirick

1.5k total citations
41 papers, 1.2k citations indexed

About

Gary R. Mirick is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Gary R. Mirick has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in Gary R. Mirick's work include Monoclonal and Polyclonal Antibodies Research (28 papers), Radiopharmaceutical Chemistry and Applications (27 papers) and Lymphoma Diagnosis and Treatment (19 papers). Gary R. Mirick is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (28 papers), Radiopharmaceutical Chemistry and Applications (27 papers) and Lymphoma Diagnosis and Treatment (19 papers). Gary R. Mirick collaborates with scholars based in United States, India and Germany. Gary R. Mirick's co-authors include Sally J. DeNardo, Gerald L. DeNardo, Robert T. OʼDonnell, Linda A. Kroger, David L. Kukis, Claude F. Meares, Sui Shen, Bonnie M. Bradt, Kathleen R. Lamborn and Arutselvan Natarajan and has published in prestigious journals such as Cancer, Clinical Cancer Research and Molecular Cancer.

In The Last Decade

Gary R. Mirick

41 papers receiving 1.1k citations

Peers

Gary R. Mirick

RNMI

PFM

ONCOL

PRM

Paul L. Beaumier United States

Zhengsheng Yao United States

Jean‐François Chatal France

Hazel B. Breitz United States

Linda A. Kroger United States

Alain Faivre-Chauvet France

Lawrence Lai United States

C. Curtet France

M W Brechbiel United States

Martina Rudelius Germany

Paul L. Beaumier United States

Gary R. Mirick

1.4k ×1.7

RNMI

193 ×0.6

PFM

480 ×1.9

ONCOL

230 ×1.0

PRM

574 ×2.7

Citations per year, relative to Gary R. Mirick Gary R. Mirick (= 1×) peers Paul L. Beaumier

Countries citing papers authored by Gary R. Mirick

Since Specialization

Citations

This map shows the geographic impact of Gary R. Mirick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Mirick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Mirick more than expected).

Fields of papers citing papers by Gary R. Mirick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. Mirick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Mirick. The network helps show where Gary R. Mirick may publish in the future.

Co-authorship network of co-authors of Gary R. Mirick

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Mirick. A scholar is included among the top collaborators of Gary R. Mirick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Mirick. Gary R. Mirick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balhorn, Rod, Saphon Hok, Sally J. DeNardo, et al.. (2009). Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells. Molecular Cancer. 8(1). 25–25. 8 indexed citations

DeNardo, Gerald L., Arutselvan Natarajan, Saphon Hok, et al.. (2008). Nanomolecular HLA-DR10 Antibody Mimics: A Potent System for Molecular Targeted Therapy and Imaging. Cancer Biotherapy and Radiopharmaceuticals. 23(6). 783–795. 8 indexed citations

Lehmann, Jöerg, Arutselvan Natarajan, Gerald L. DeNardo, et al.. (2008). Short Communication: Nanoparticle Thermotherapy and External Beam Radiation Therapy for Human Prostate Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 23(2). 265–271. 11 indexed citations

Dadachova, Ekaterina, Ekaterina Revskaya, R. C. Boucher, et al.. (2008). Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice. Cancer Biology & Therapy. 7(7). 1116–1127. 44 indexed citations

DeNardo, Gerald L., Arutselvan Natarajan, Saphon Hok, et al.. (2007). Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma. Journal of Nuclear Medicine. 48(8). 1338–1347. 74 indexed citations

DeNardo, Gerald L., Saphon Hok, Arutselvan Natarajan, et al.. (2007). Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma. International Journal of Oncology. 31(4). 729–40. 10 indexed citations

Azinovic, Ignacio, Gerald L. DeNardo, Kathleen R. Lamborn, et al.. (2006). Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies. Cancer Immunology Immunotherapy. 55(12). 1451–1458. 33 indexed citations

Bradt, Bonnie M., Sally J. DeNardo, Gary R. Mirick, & Gerald L. DeNardo. (2003). Documentation of Idiotypic Cascade after Lym-1 Radioimmunotherapy in a Patient with Non-Hodgkin’s Lymphoma. Clinical Cancer Research. 9(10). 1 indexed citations

DeNardo, Gerald L., Bonnie M. Bradt, Gary R. Mirick, & Sally J. DeNardo. (2003). Human antiglobulin response to foreign antibodies: therapeutic benefit?. Cancer Immunology Immunotherapy. 52(5). 309–316. 36 indexed citations

10.

OʼDonnell, Robert T., Sally J. DeNardo, A. Yuan, et al.. (2001). Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.. PubMed. 7(6). 1561–8. 42 indexed citations

11.

DeNardo, Gerald L., Robert T. OʼDonnell, Larry Rose, et al.. (1999). Milestones in the Development of Lym-1 Therapy. Hybridoma. 18(1). 1–11. 24 indexed citations

12.

Mirick, Gary R., Robert T. OʼDonnell, Sally J. DeNardo, et al.. (1999). Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients. Nuclear Medicine and Biology. 26(7). 841–845. 56 indexed citations

13.

DeNardo, Sally J., Linda A. Kroger, Malcolm R. MacKenzie, et al.. (1998). Prolonged Survival Associated with Immune Response in a Patient Treated with Lym-1 Mouse Monoclonal Antibody. Cancer Biotherapy and Radiopharmaceuticals. 13(1). 1–12. 16 indexed citations

14.

OʼDonnell, Robert T., Sally J. DeNardo, Xu-Bao Shi, et al.. (1998). L6 monoclonal antibody binds prostate cancer. The Prostate. 37(2). 91–97. 20 indexed citations

15.

DeNardo, Gerald L., Sally J. DeNardo, David L. Kukis, et al.. (1998). Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.. PubMed. 18(4B). 2779–88. 53 indexed citations

16.

OʼDonnell, Robert T., Sally J. DeNardo, Laird Miers, et al.. (1998). Combined Modality Radioimmunotherapy with Taxol and ⁹⁰ Y-LYM-1 for Raji Lymphoma Xenografts. Cancer Biotherapy and Radiopharmaceuticals. 13(5). 351–361. 28 indexed citations

17.

DeNardo, Sally J., Gary R. Mirick, Linda A. Kroger, et al.. (1994). The biologic window for chimeric l6 radioimmunotherapy. Cancer. 73(S3). 1023–1032. 42 indexed citations

18.

DeNardo, Gerald L., M.-A. Mahé, Sally J. DeNardo, et al.. (1993). Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignancies. Nuclear Medicine Communications. 14(1). 587–595. 31 indexed citations

19.

Andrews, Brian S., George J. Friou, M A Berman, et al.. (1987). Changes in circulating monocytes in patients with progressive systemic sclerosis.. PubMed. 14(5). 930–5. 18 indexed citations

20.

Andrews, Brian S., et al.. (1986). Immunopathology of cutaneous human lupus erythematosus defined by murine monoclonal antibodies. Journal of the American Academy of Dermatology. 15(3). 474–481. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact